2 Notes on the scope of the guidance

2 Notes on the scope of the guidance

NICE guidelines are developed in accordance with a scope that defines what the guideline will and will not cover.

This guideline is relevant to adults and young people who are opioid dependent and have made an informed decision to take part in a detoxification programme. The guideline will be of relevance to the NHS, in particular inpatient and specialist residential and community-based treatment settings, and related organisations, including prison services. Although the guideline may comment on the interface with other services, such as those provided by the voluntary sector, it will not provide specific recommendations directed solely at non-NHS services, except in so far as they are provided under contract to the NHS.

The guideline does not specifically address:

  • people whose primary drug of misuse is not an opioid

  • people who misuse alcohol, prescription drugs or solvents

  • diagnosis or primary prevention

  • pharmacological maintenance programmes

  • people younger than 16¬†years.

How this guideline was developed

NICE commissioned the National Collaborating Centre for Mental Health to develop this guideline. The Centre established a Guideline Development Group (see appendix A), which reviewed the evidence and developed the recommendations. An independent Guideline Review Panel oversaw the development of the guideline (see appendix B).

There is more information about how NICE clinical guidelines are developed on the NICE website. A booklet, 'How NICE clinical guidelines are developed: an overview for stakeholders, the public and the NHS' is available.

  • National Institute for Health and Care Excellence (NICE)